Literature DB >> 23524888

Strategies to prevent hepatitis B virus infection in China: immunization, screening, and standard medical practices.

Chunyu Zhang1, Yuesi Zhong, Liping Guo.   

Abstract

China has one of the world's highest rates of hepatitis B infection. Over the past 20 years, a series of strategies have been implemented to prevent infection with the hepatitis B virus (HBV) in China. These strategies include hepatitis B (hepB) immunization for susceptible populations such as infants and young children and for high-risk populations such as health care workers and patients, premarital health care for couples of childbearing age, and standard medical practices. A series of measures implemented by the Chinese government caused the HBV infection rate in China to decrease from 9.75% in 1992 to 7.2% in 2006. However, a report on infectious diseases indicated that more than 1 million people in China were infected with hepB in 2011. There is room for improvement. The current work analyzed the current status of and challenges for strategies to prevent HBV infection in China. This work also recommends clear guidance regarding hepB immunization for parents in rural areas, more flexible premarital health care, health education for both patients and health care workers, and routine HBV screening for high-risk health care workers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23524888

Source DB:  PubMed          Journal:  Biosci Trends        ISSN: 1881-7815            Impact factor:   2.400


  11 in total

Review 1.  Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma.

Authors:  Pei-Pei Song; Ju-Feng Xia; Yoshinori Inagaki; Kiyoshi Hasegawa; Yoshihiro Sakamoto; Norihiro Kokudo; Wei Tang
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

2.  Three decades of hepatitis B control with vaccination.

Authors:  Liliane C Meireles; Rui Tato Marinho; Pierre Van Damme
Journal:  World J Hepatol       Date:  2015-08-28

3.  Hepatitis B-related knowledge and vaccination in association with discrimination against Hepatitis B in rural China.

Authors:  Lijie Yu; Jian Wang; Dawei Zhu; Anli Leng; Knut R Wangen
Journal:  Hum Vaccin Immunother       Date:  2015-07-25       Impact factor: 3.452

4.  Factors associated with adults' perceived need to vaccinate against hepatitis B in rural China.

Authors:  Lijie Yu; Jian Wang; Knut R Wangen; Ruohan Chen; Elizabeth Maitland; Stephen Nicholas
Journal:  Hum Vaccin Immunother       Date:  2016-04-04       Impact factor: 3.452

5.  Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): study protocol for a randomized controlled trial.

Authors:  Jianhui Qu; Zujiang Yu; Qin Li; Yongping Chen; Dedong Xiang; Lin Tan; Chunliang Lei; Wenlin Bai; Hongyan Li; Qinghua Shang; Liang Chen; Xiaoyu Hu; Wei Lu; Zhiqin Li; Da Chen; Xiaodong Wang; Changjiang Zhang; Guangming Xiao; Xun Qi; Jing Chen; Li Zhou; Guofeng Chen; Yonggang Li; Zhen Zeng; Guanghua Rong; Zheng Dong; Yan Chen; Min Lou; Chunping Wang; Yinying Lu; Cuihong Zhang; Yongping Yang
Journal:  Trials       Date:  2014-11-10       Impact factor: 2.279

6.  Entecavir versus Lamivudine therapy for patients with chronic hepatitis B-associated liver failure: a meta-analysis.

Authors:  Xiaoguo Zhang; Yong An; Xuemei Jiang; Minling Xu; Linlin Xu; Shijun Chen; Yaguang Xi
Journal:  Hepat Mon       Date:  2014-11-11       Impact factor: 0.660

Review 7.  Increasing Coverage of Hepatitis B Vaccination in China: A Systematic Review of Interventions and Implementation Experiences.

Authors:  Shengnan Wang; Helen Smith; Zhuoxin Peng; Biao Xu; Weibing Wang
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

8.  Serum Biomarkers AFP, CEA and CA19-9 Combined Detection for Early Diagnosis of Hepatocellular Carcinoma.

Authors:  Muhammad Ibrahim Alhadi Edoo; Vikram Kumar Chutturghoon; Gyabaah Kwabena Wusu-Ansah; Hai Zhu; Tao Yang Zhen; Hai Yang Xie; Shu-Sen Zheng
Journal:  Iran J Public Health       Date:  2019-02       Impact factor: 1.429

9.  Improved Variable Selection Algorithm Using a LASSO-Type Penalty, with an Application to Assessing Hepatitis B Infection Relevant Factors in Community Residents.

Authors:  Pi Guo; Fangfang Zeng; Xiaomin Hu; Dingmei Zhang; Shuming Zhu; Yu Deng; Yuantao Hao
Journal:  PLoS One       Date:  2015-07-27       Impact factor: 3.240

Review 10.  Clinical utility of entecavir for chronic hepatitis B in Chinese patients.

Authors:  Jiyao Wang
Journal:  Drug Des Devel Ther       Date:  2013-12-12       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.